Limertinib (ASK120067) is an orally active and highly efficient epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor targeting EGFR T790M. Limertinib can be used for studying non-small cell lung cancer.
Molecular Weight:
546.06
Purity:
97.44%
CAS Number:
[1934259-00-3]
Formula:
C29H32ClN7O2
Target:
EGFR
T35897
T35897
* VAT and and shipping costs not included. Errors and price changes excepted